课题基金 / 基金详情

Cross-talk between angiotensin II receptor and cytokines in vascular disease

Cross-talk between angiotensin II receptor and cytokines in vascular disease
血管疾病中血管紧张素 II 受体与细胞因子之间的相互作用
批准号:
12470156
负责人:
HORIUCHI Masatsugu
金额:
$8.7万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

HORIUCHI Masatsugu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neointimal formation and DNA synthesis in vascular smooth muscle cell (VSMC) after cuff placement in the femoral artery were exaggerated in AT2 receptor null mice, but suppressed in AT1a receptor null mice. The number of apoptotic cells in VSMC in the injured artery was significantly increased in AT1a receptor null mice, but decreased in AT2 receptor null mice. Moreover, cuff placement increased the expression of MCP-1, inflammatory cytokines such as TNF-a, IL-6, and IL-1b and infiltration of CD45-positive leukocytes and macrophage in the injured arteries and further enhanced in AT2 receptor null mice, suggesting the antagonistic effects of AT1 and AT2 receptors and vascular inflammation. We also demonstrated that AT2 receptor was expressed in human coronary atherosclerotic lesions. We have identified the interferon regulatory factor (IRF) binding motif in a negative regulatory region between positions -453 and -225, and demonstrated that the expression of AT2 receptor in these cells is transcriptionally regulated by the competitive binding of two related IRFs (IRF-1 and IRF-2) and demonstrated that that IFN-g upregulated AT2 receptor expression in R3T3 cells via the activation of the intracellular Jak/STAT pathway and production of IRF-1. To test the physiological relevance of the role of IRF-1 in vascular remodeling, we employed IRF-1 null mice and observed that AT2 receptor expression was low associated with increase in neointimal formation, increase in DNA synthesis in VSMC, and decrease in apoptotic changes in VSMC in the injured artery of IRF-1 null mice compared to those in wild type mice.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Akishita, M., Shirakami, G., Iwai, M., Lan., W., Aoki, M., Zhang, L., Toba, K., Horiuchi, M: "Angiotensin Converting Enzyme Inhibitor Restrains Inflammation Induced Vascular Injury in Mice"J. Hypertens.. 19・6. 1083-1088 (2001)
Akishita, M.、Shirakami, G.、Iwai, M.、Lan.、W.、Aoki, M.、Zhang, L.、Toba, K.、Horiuchi, M:“血管紧张素转换酶抑制剂抑制炎症引起的血管损伤小鼠”J. Hypertens.. 19・6. 1083-1088 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Akishita, M., Horiuchi, M., Yamada, H., Zhang, L, Shirakami, G., Tamura, K., Ouchi, Y. and Dzau, V.J.: "Inflammation influences vascular remodering through AT2 receptor expression and signaling"Physiol Genomics. 2. 13-30 (2000)
Akishita, M.、Horiuchi, M.、Yamada, H.、Zhang, L、Shirakami, G.、Tamura, K.、Ouchi, Y. 和 Dzau, V.J.:“炎症通过 AT2 受体表达和信号传导影响血管重塑”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Roles of Angiotensin II Receptor-Associated Protein in Vascular Senescence
    • 批准号:
      21390242
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2009
    • 负责人:
      HORIUCHI Masatsugu
    • 依托单位:
    New Therapeutic Approach Using Novel Nuclear Translocating Signaling Protein Against Vascular Remodeling and Atherosclerosis
    • 批准号:
      18390235
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2006
    • 负责人:
      HORIUCHI Masatsugu
    • 依托单位:
    Therapeutic application of vascular diseases by novel angiotensin II receptor signal regulating molecule
    • 批准号:
      15390247
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2003
    • 负责人:
      HORIUCHI Masatsugu
    • 依托单位:
    Molecular mechanism vascular remodeling and blood pressure regulation by orphan receptor, and theraputic
    • 批准号:
      12557064
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.26万
    • 财政年份:
      2000
    • 负责人:
      HORIUCHI Masatsugu
    • 依托单位:
    国内基金
    海外基金
    盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
    • 批准号:
      82372202
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      侯旭敏
    • 依托单位:
    GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
    • 批准号:
      82371652
    • 项目类别:
      面上项目
    • 资助金额:
      45.00万元
    • 批准年份:
      2023
    • 负责人:
      刘开江
    • 依托单位:
    多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
    • 批准号:
      82370797
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      陶弢
    • 依托单位:
    G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
    • 批准号:
      82370865
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      黄哲
    • 依托单位: